(Q72886154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Dose response evaluation. Use of plasma concentration confidence intervals as a tool to predict optimal drug dose ratio (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 July 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354015%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-199325010-00001

30 October 2019

exact match

0 references

cites work

Single-dose and steady-state pharmacokinetics of aminoglutethimide.

1 reference

12 December 2020

High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer

1 reference

12 December 2020

Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer

1 reference

12 December 2020

Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day

1 reference

12 December 2020

Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerations

1 reference

12 December 2020

Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses

1 reference

12 December 2020

Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer

1 reference

12 December 2020